TY  - JOUR
AU  - Pasquau, Juan
AU  - Hidalgo-Tenorio, Carmen
AU  - Montes, Maria Luisa
AU  - Romero-Palacios, Alberto
AU  - Vergas, Jorge
AU  - Sanjoaquín, Isabel
AU  - Hernandez-Quero, Jose
AU  - Aguirrebengoa, Koldo
AU  - Orihuela, Francisco
AU  - Imaz, Arkaitz
AU  - Rios-Villegas, Maria Jose
AU  - Flores, Juan
AU  - Fariñas, Maria Carmen
AU  - Vazquez, Pilar
AU  - Galindo, Maria Jose
AU  - Garcia-Merce, Isabel
AU  - Lozano, Fernando
AU  - de-Los-Santos, Ignacio
AU  - de-Jesus, Samantha Elizabeth
AU  - Garcia-Vallecillos, Coral
PY  - 2018
DO  - 10.1371/journal.pone.0195068
UR  - http://hdl.handle.net/10668/12337
T2  - PloS one
AB  - The QoLKAMON study evaluated quality of life, efficacy and treatment safety in HIV patients receiving lopinavir/ritonavir in monotherapy (MT) versus continuing combined antiretroviral triple treatment with a boosted protease inhibitor (TT). This was a...
LA  - en
PB  - Public Library of Science
KW  - Área de Gestión Sanitaria Sur de Sevilla
KW  - Anti-HIV Agents
KW  - CD4 Lymphocyte Count
KW  - HIV Infections
KW  - HIV Protease Inhibitors
KW  - Adult
KW  - Female
KW  - HIV-1
KW  - Humans
KW  - Lopinavir
KW  - Male
KW  - Middle Aged
KW  - Quality of Life
KW  - Reproducibility of Results
KW  - Ritonavir
KW  - Spain
KW  - Surveys and Questionnaires
KW  - Treatment Outcome
KW  - Viral Load
TI  - High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial.
TY  - research article
VL  - 13
ER  -